{
    "nct_id": "NCT06220864",
    "official_title": "A Phase 1, Open-Label Dose Escalation and Expansion Study of SNV1521 in Participants with Advanced Solid Tumors",
    "inclusion_criteria": "* Advanced or metastatic solid tumor malignancy\n* Evaluable or Measurable disease (RECIST 1.1 Criteria).\n* ECOG Performance Status 0 or 1.\n* Life expectancy > 3 months\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of other malignancy within the past 2 years\n* Prior diagnosis of Myelodysplastic syndrome or Acute Myeloid Leukemia\n* Significant cardiovascular disease within 6 months\n* Significant gastrointestinal disease\n* HIV infection with a CD4+ T-cell count < 200 cells/Î¼L and/or a detectable viral load\n* Liver dysfunction",
    "miscellaneous_criteria": ""
}